Abstract
Autism Spectrum Disorder (ASD) includes a group of neurodevelopmental disorders characterized by core symptoms such as impaired social interaction and communication, repetitive and stereotyped behaviors, and restricted interests. To date, there are no effective treatments for these core symptoms. Several studies have shown that the brain serotonin (5-HT) neurotransmission system is altered in both ASD patients and animal models of the disease. Multiple pieces of evidence suggest that targeting 5-HT receptors may treat the core symptoms of ASD and associated intellectual disabilities. In fact, stimulation of the 5-HT1A receptor reduces repetitive and restricted behaviors, blockade of the 5-HT2A receptor reduces both learning deficits and repetitive behavior, and activation of the 5-HT7 receptor improves cognitive performances and reduces repetitive behavior. On such a basis, a set of novel arylpiperazine derivatives have been synthesized by pursuing unprecedently reported activity profiles: dual 5-HT1A/5-HT7 receptor agonist properties and mixed 5-HT1A agonist/5-HT7 agonist/5-HT2A antagonist properties. Dual 5-HT1AR/5-HT7R agonists and the mixed 5-HT1AR agonist/5-HT7R agonist/5-HT2AR antagonists have been identified. These compounds are metabolically stable in vitro and have suitable central nervous system drug-like properties.
Highlights
Autism Spectrum Disorder (ASD) refers to a group of neurodevelopmental disorder characterized by: Persistent deficits in social communication and social interaction across multiple contexts Restricted, repetitive patterns of behavior, interests, or activitiesThe frequency of ASD is increasing, with present rates of about 1 in 100 children in Europe and 1 in 54 in the United StatesEtiological Factors NeuropathologiesBehavioral abnormalitiesComorbidities
Current psychotropic drugs do not treat core symptoms of ASD. These medicines treat irritability associated with the ASD
Platelet hyperserotonemia: ∼70% increase of 5-HT level in platelet is observed in ∼30% of ASD patients
Summary
Autism Spectrum Disorder (ASD) refers to a group of neurodevelopmental disorder characterized by: Persistent deficits in social communication and social interaction across multiple contexts Restricted, repetitive patterns of behavior, interests, or activities (as defined by the Diagnostic and Statistical Manual of Mental Disorders DSM–5)The frequency of ASD is increasing, with present rates of about 1 in 100 children in Europe and 1 in 54 in the United States (www.cdc.gov/ncbddd/autism/data.html)Etiological Factors NeuropathologiesBehavioral abnormalitiesComorbidities Autism Spectrum Disorder (ASD) refers to a group of neurodevelopmental disorder characterized by: The frequency of ASD is increasing, with present rates of about 1 in 100 children in Europe and 1 in 54 in the United States (www.cdc.gov/ncbddd/autism/data.html) Current psychotropic drugs do not treat core symptoms of ASD These medicines treat irritability associated with the ASD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.